NPRL2 Gene

NPRL2 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NPRL2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NPRL2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NPR2-Like (GATOR1 Complex Subunit)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10316</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000131653</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8WX92</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GATOR1</td>
<td>Rag GAP activity</td>
</tr>
<tr>
<td class="label">GATOR2</td>
<td>Positive regulator</td>
</tr>
<tr>
<td class="label">Sestrin1/2</td>
<td>Leucine sensing</td>
</tr>
<tr>
<td class="label">CASTOR1/2</td>
<td>Arginine sensing</td>
</tr>
<tr>
<td class="label">SAMTOR</td>
<td>Methionine sensing</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">DEPDC5</td>
<td>GATOR1 subunit</td>
</tr>
<tr>
<td class="label">TSC1/2</td>
<td>Parallel mTOR regulation</td>
</tr>
<tr>
<td class="label">FLCN</td>
<td>mTOR regulation</td>
</tr>
<tr>
<td class="label">PTEN</td>
<td>PI3K-mTOR pathway</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Sirolimus (Ra

NPRL2 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NPRL2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NPRL2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NPR2-Like (GATOR1 Complex Subunit)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10316</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000131653</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8WX92</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GATOR1</td>
<td>Rag GAP activity</td>
</tr>
<tr>
<td class="label">GATOR2</td>
<td>Positive regulator</td>
</tr>
<tr>
<td class="label">Sestrin1/2</td>
<td>Leucine sensing</td>
</tr>
<tr>
<td class="label">CASTOR1/2</td>
<td>Arginine sensing</td>
</tr>
<tr>
<td class="label">SAMTOR</td>
<td>Methionine sensing</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">DEPDC5</td>
<td>GATOR1 subunit</td>
</tr>
<tr>
<td class="label">TSC1/2</td>
<td>Parallel mTOR regulation</td>
</tr>
<tr>
<td class="label">FLCN</td>
<td>mTOR regulation</td>
</tr>
<tr>
<td class="label">PTEN</td>
<td>PI3K-mTOR pathway</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Sirolimus (Rapamycin)</td>
<td>Allosteric mTORC1 inhibitor</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>Rapamycin analog</td>
</tr>
<tr>
<td class="label">Torin1</td>
<td>Catalytic mTOR inhibitor</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Function</td>
</tr>
<tr>
<td class="label">NPRL2</td>
<td>Catalytic GAP activity</td>
</tr>
<tr>
<td class="label">NPRL3</td>
<td>Structural scaffold</td>
</tr>
<tr>
<td class="label">DEPDC5</td>
<td>Regulatory subunit</td>
</tr>
<tr>
<td class="label">Autophagy Stage</td>
<td>NPRL2 Effect</td>
</tr>
<tr>
<td class="label">Initiation</td>
<td>ULK1 complex activation</td>
</tr>
<tr>
<td class="label">Nucleation</td>
<td>PI3K-III complex recruitment</td>
</tr>
<tr>
<td class="label">Elongation</td>
<td>LC3 lipidation</td>
</tr>
<tr>
<td class="label">Fusion</td>
<td>Autophagosome-lysosome fusion</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>NPRL2 Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Interneurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Seizure type</td>
<td>Focal seizures, often with auditory features</td>
</tr>
<tr>
<td class="label">Onset</td>
<td>Childhood to adolescence</td>
</tr>
<tr>
<td class="label">Penetrance</td>
<td>Incomplete (60-70%)</td>
</tr>
<tr>
<td class="label">EEG findings</td>
<td>Temporal/focal epileptiform discharges</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Rapamycin</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">Torin1</td>
<td>mTORC1/mTORC2</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">AMPK</td>
<td>Energy sensing</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Autophagy initiation</td>
</tr>
<tr>
<td class="label">TFEB</td>
<td>Lysosomal biogenesis</td>
</tr>
<tr>
<td class="label">Wnt</td>
<td>Developmental signaling</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Yeast</td>
<td>Basic mechanisms</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Development</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>Development, screening</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>In vivo models</td>
</tr>
<tr>
<td class="label">iPSC neurons</td>
<td>Disease modeling</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">mTORC1</td>
<td>Inhibition</td>
</tr>
<tr>
<td class="label">GATOR1</td>
<td>Stabilization</td>
</tr>
<tr>
<td class="label">Autophagy</td>
<td>Induction</td>
</tr>
<tr>
<td class="label">Metabotropic</td>
<td>Ketogenic diet</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

Nprl2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Gene Information

Protein Structure

• GAP activity towards Rag GTPases
• Protein-protein interaction domains
• Multiple phosphorylation sites

Molecular Function

Expression Pattern

• High in brain, heart, kidney
• Moderate in liver, lung
• Low in other tissues

• [Neurons](/entities/neurons) in [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• Cerebellar Purkinje cells
• Glial cells

Disease Associations

Focal Epilepsy

• Autosomal dominant focal epilepsy (FLE)
• Mutations cause epilepsy without brain lesions
• Incomplete penetrance
• PMID: 23471845(https://pubmed.ncbi.nlm.nih.gov/23471845/), PMID: 23695510(https://pubmed.ncbi.nlm.nih.gov/23695510/)

Alzheimer's Disease

• mTORC1 hyperactivation in AD
• Impaired autophagy leads to protein aggregation
• Synaptic plasticity deficits
• PMID: 25396082(https://pubmed.ncbi.nlm.nih.gov/25396082/), PMID: 26255403(https://pubmed.ncbi.nlm.nih.gov/26255403/)

Parkinson's Disease

• Dysregulated [mTOR](/mechanisms/mtor-signaling-pathway) signaling
• [Autophagy](/entities/autophagy) defects in PD
• [Alpha-synuclein](/proteins/alpha-synuclein) accumulation
• PMID: 26925799(https://pubmed.ncbi.nlm.nih.gov/26925799/), PMID: 28749530(https://pubmed.ncbi.nlm.nih.gov/28749530/)

Tuberous Sclerosis

• Related to TSC1/TSC2 pathway
• mTOR hyperactivation
• Seizures and developmental issues

Cancer

• Tumor suppressor
• Loss in various cancers
• Renal cell carcinoma

Therapeutic Implications

• mTOR Inhibitors: Rapamycin, everolimus
• Autophagy Inducers: Trehalose, resveratrol
• Ketogenic Diet: Bypasses mTOR dysregulation
• Gene Therapy: For epilepsy

Animal Models

• Nprl2 knockout mice: Embryonic lethal
• Conditional knockouts: Seizures, autism-like behaviors
• Zebrafish: Developmental defects

Background

The study of Nprl2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [DEPDC5 Gene complex subunit - GATOR1](/genes/depdc5)
• GATOR Complex - Amino acid sensing
• [mTOR Pathway - Growth regulation](/entities/mtor)
• [Autophagy](/entities/autophagy)-Lysosomal Pathway - Protein clearance
• [Epilepsy - Primary disease](/diseases/epilepsy)
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease association

External Links

• [NCBI Gene NPRL2](https://www.ncbi.nlm.nih.gov/gene/10316)
• [UniProt Q8WX92](https://www.uniprot.org/uniprotkb/Q8WX92)
• [HGNC NPRL2](https://www.genenames.org/data/hgnc_data.php?hgnc_id=8004)
• [Ensembl NPRL2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131653)

Molecular Mechanisms

GATOR1 Complex Assembly and Function

The GATOR1 complex represents the primary amino acid sensing machinery that negatively regulates mTORC1 signaling[gator]. NPRL2 serves as the central scaffold that coordinates complex assembly:

The complete complex has a molecular weight of approximately 350 kDa and localizes primarily to the cytosol, with enrichment at the lysosomal surface where mTORC1 activation occurs.

Rag GTPase Regulation

NPRL2 directly catalyzes GTP hydrolysis on Rag GTPases, a critical regulatory step:

• Rag GTPase structure: Heterodimers of RagA/B (or Rag1/2) with RagC/D (or Rag3/4)
• Active state: RagA/B-GTP recruits mTORC1 to the lysosomal surface
• Inactive state: GDP-bound Rags prevent mTORC1 recruitment
• NPRL2 GAP activity: Accelerates GTP hydrolysis on RagA/B by ~10,000-fold
• Substrate specificity: Prefers RagA over RagB; exhibits some specificity for RagC

Amino Acid Sensing Pathway

The GATOR1 complex functions within a larger amino acid sensing network:

Integration with Cellular Metabolic Status

NPRL2 function intersects with multiple metabolic pathways:

• AMPK signaling: Energy depletion activates AMPK, which phosphorylates and inhibits mTORC1 through TSC1/2
• Growth factor signaling: PI3K-Akt pathway modulates mTORC1 activity independently of amino acids
• Stress responses: p53 and hypoxia-inducible factor pathways affect GATOR1 function

Neurological Disease Mechanisms

Alzheimer's Disease Pathogenesis

In Alzheimer's disease, NPRL2 dysfunction contributes to several key pathological features:

• mTORC1 hyperactivation: Reduced GATOR1 activity permits uncontrolled mTORC1 signaling
• Autophagy impairment: Active mTORC1 inhibits autophagy initiation, blocking clearance of Aβ and tau
• Synaptic dysfunction: mTOR-regulated local protein synthesis at synapses becomes dysregulated
• Protein synthesis dysregulation: Aberrant phosphorylation of 4E-BP and S6K affects synaptic plasticity

Parkinson's Disease Mechanisms

NPRL2 alterations in PD involve:

• mTOR pathway dysregulation: Altered mTOR signaling in dopaminergic neurons
• Autophagy defects: Impaired autophagic clearance of alpha-synuclein aggregates
• Lysosomal dysfunction: Connection to GBA and other lysosomal genes mutated in PD
• Neuronal vulnerability: Enhanced susceptibility of substantia nigra neurons

Epilepsy Pathophysiology

NPRL2 mutations cause focal epilepsy through[nprl]:

Interaction with Other Neurodegeneration Genes

NPRL2 interacts with multiple genes implicated in neurodegeneration:

Therapeutic Strategies

mTOR Inhibitors in Clinical Practice

Autophagy-Inducing Strategies

Beyond mTOR inhibition, alternative autophagy enhancement approaches:

• Trehalose: mTOR-independent autophagy inducer
• Resveratrol: SIRT1-dependent autophagy activation
• Lithium: IMPase inhibition, inositol depletion
• Carbamazepine: TFEB activation

Gene Therapy Approaches

For NPRL2-related epilepsy:

• AAV-mediated delivery: Brain-targeted vector systems
• CRISPR-based correction: Allele-specific editing
• Antisense oligonucleotides: Variant-specific targeting

Ketogenic Diet Therapy

Metabolic therapy offers an alternative approach:

• Mechanism: Reduces glycolysis, increases ketone utilization
• Effect on mTOR: Decreases mTORC1 signaling through AMPK activation
• Benefits: Seizure reduction, improved cognition
• Considerations: Dietary compliance, lipid profile

Research Models and Methods

Cellular Models

• Neuronal cultures: Primary cortical and hippocampal neurons
• iPSC-derived neurons: Patient-specific disease modeling
• Organotypic slices: Preserved brain architecture

Animal Models

• Nprl2 knockout mice: Embryonic lethal (E7.5-9.5)
• Conditional knockouts: Brain-specific deletion for survival
• heterozygous mice: Show behavioral abnormalities

Experimental Approaches

• CRISPR/Cas9: Gene editing for mutation modeling
• Proteomics: GATOR1 complex composition analysis
• Metabolomics: Metabolic pathway profiling
• Single-cell RNAseq: Cell type-specific expression

Biomarkers and Diagnostics

Genetic Testing

• Panel testing: Epilepsy gene panels including NPRL2
• Whole exome sequencing: Comprehensive variant detection
• Family screening: Cascade testing for relatives

Functional Assays

• Fibroblast studies: mTORC1 hyperactivation assessment
• Protein expression: Western blot for NPRL2 levels
• Enzyme activity: Rag GAP activity measurement

Summary

NPRL2 (NPR2-Like, GATOR1 Complex Subunit) encodes a core component of the GATOR1 complex, the primary negative regulator of mTORC1 signaling in response to amino acid availability. Through its catalytic GAP activity toward Rag GTPases, NPRL2 plays essential roles in nutrient sensing, autophagy regulation, protein synthesis control, and cellular growth decisions. Mutations in NPRL2 cause autosomal dominant focal epilepsy, while dysregulated mTORC1 signaling contributes to Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Understanding NPRL2 function provides insights into the pathogenesis of these conditions and identifies therapeutic targets for intervention.

Brain Atlas Resources

• Allen Human Brain Atlas: [Gene expression search](https://human.brain-map.org/microarray/search/show?search_term=NPRL2)
• Allen Mouse Brain Atlas: [Gene search](https://mouse.brain-map.org/search/index.html?query=NPRL2)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Developmental Transcriptome: [Developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=NPRL2)

References

GATOR1 Complex Architecture

Structure and Composition

The GATOR1 complex is a multi-subunit complex that functions as the primary negative regulator of mTORC1 signaling in response to amino acid starvation. NPRL2 forms the catalytic core of this complex[@gator]:

Each component plays distinct roles:

Rag GTPase Regulation

NPRL2 functions as a GTPase-activating protein (GAP) for Rag GTPases[@gator]:

• RagA/RagB: Rag heterodimers sense amino acid availability
• GTP hydrolysis: NPRL2 promotes Rag inactivation
• mTORC1 recruitment: Inactive Rag prevents mTORC1 lysosomal localization
• Amino acid sensing: Links nutrient status to growth signaling

Molecular Mechanisms

mTORC1 Signaling Pathway

The mTOR (mechanistic target of rapamycin) pathway is a central regulator of cell growth and metabolism[@mtor]:

Autophagy Regulation

NPRL2 indirectly regulates autophagy through mTORC1 inhibition[@autophagy]:

When NPRL2 is functional, mTORC1 remains inhibited, permitting autophagy to proceed. Loss of NPRL2 function leads to mTORC1 hyperactivation and autophagy blockade.

Brain-Specific Functions

Neuronal mTOR Regulation

In neurons, NPRL2-mediated mTOR regulation has unique features[@mechanisms]:

• Synaptic plasticity: mTOR controls local protein synthesis at synapses
• Neuronal morphology: Regulates dendritic arborization and spine formation
• Activity-dependent translation: Links neural activity to protein synthesis
• Circuit refinement: mTOR dysregulation affects circuit development

Cell Type-Specific Expression

Epilepsy Mechanisms

Focal Epilepsy

NPRL2 mutations cause autosomal dominant focal epilepsy[@nprl]:

The mechanism involves:

mTORopathies

NPRL2-related epilepsy is part of a broader group of "mTORopathies":

• Focal cortical dysplasia
• Tuberous sclerosis
• Hemimegalencephaly
• DEPDC5-related epilepsy

Therapeutic Approaches

mTOR Inhibitors

Clinical considerations:

• Efficacy: Significant seizure reduction in many patients
• Adverse effects: Immunosuppression, metabolic effects
• Treatment duration: Often lifelong
• Combination therapy: May enable dose reduction

Autophagy Induction

Alternative approaches target autophagy directly[@autophagy]:

• Trehalose: mTOR-independent autophagy inducer
• Resveratrol: SIRT1-dependent autophagy
• Lithium: Autophagy through IMPase inhibition
• Carbamazepine: Autophagy enhancement

Structural Biology

Protein Domain Architecture

NPRL2 contains several functional domains:

Structural Studies

Cryo-EM studies have elucidated:

• GATOR1 complex architecture
• NPRL2-NPRL3 interaction
• Rag GTPase binding conformation

Signaling Networks

Amino Acid Sensing Pathway

Integration with Other Pathways

NPRL2 intersects with multiple signaling networks:

Clinical Implications

Diagnosis

Genetic testing for NPRL2 variants:

• Sequencing: Panel or whole exome
• Interpretation: Pathogenic vs. VUS
• Family testing: Cascade screening

Prenatal Testing

Available for:

• Known familial variants
• Preimplantation testing
• Carrier testing

Research Tools

Model Systems

Experimental Techniques

• CRISPR/Cas9 editing
• Proteomics
• Metabolomics
• Single-cell RNAseq

Therapeutic Development

Drug Targets

Clinical Trial Design

Considerations for NPRL2-related epilepsy:

• Genotype-phenotype correlation
• Seizure frequency endpoints
• Quality of life measures
• Long-term outcomes

Biomarkers

Therapeutic Response Markers

• Seizure frequency
• EEG normalization
• Cognitive function
• Brain imaging

Disease Progression

• Developmental milestones
• Neurological exam
• Biomarker levels

See Also

Pathway Diagram

The following diagram shows the key molecular relationships involving NPRL2 Gene discovered through SciDEX knowledge graph analysis: